Navigation Links
VetStem Biopharma is Pleased to Share the Success Story of Sam Who was Treated with Stem Cell Therapy by Dr. Lucy Roberts at Animal Medical Center of Tuscaloosa

At five years old, Sam began having issues with his liver. X-Rays were taken to look for a possible tumor and instead, Sam’s veterinarian found that he had arthritis in his lower, or lumbosacral, spine. At the time, he was not experiencing any obvious discomfort, so his owner placed him on supplements for the arthritis and monitored his activity.

Within two years, Sam began slowing down and stopped wanting to take his daily walks. Sam’s owner took him to Dr. Lucy Roberts of Animal Medical Center of Tuscaloosa. Upon examination, it was determined that Sam’s range of motion was at 60% of what it should be in all four legs. He was started on an injectable medication and acupuncture. The combination of treatments seemed to help quite a bit and Sam was able to resume his daily walks.

Unfortunately, the relief Sam experienced was short lived. About nine months later, he began showing symptoms of discomfort again. This time, Dr. Roberts recommended using the tissue processing services at VetStem Biopharma. VetStem Regenerative Cell Therapy is a process by which a veterinarian collects a sample of fat tissue from a patient and sends it to the VetStem laboratory where the regenerative cells are separated from the fat tissue. The cells are returned to the veterinarian for appropriate injection techniques as determined by the attending veterinarian.

In March of 2017, Sam had full body X-Rays, which confirmed he had arthritis in both shoulders and both hips, along with the arthritis in his spine. Dr. Roberts then collected fat from Sam’s abdomen during a minimally invasive anesthetic procedure. The fat was aseptically packaged and shipped overnight to VetStem’s laboratory in San Diego, California. VetStem lab technicians processed Sam’s fat and prepared injectable doses of Sam’s own stem and regenerative cells to be shipped back to Dr. Roberts. Approximately 48 hours after the initial fat collection procedure, Sam received injections in both shoulders, both hips, intravenously and in the muscle along his spinal column (paraspinal).

Typically, when treating more complicated conditions such as spinal arthritis, a follow-up treatment is performed one to two weeks after the initial treatment. Depending on the severity of the spinal arthritis and the preference of the treating veterinarian, the follow up treatment may be an intravenous injection only or it may be a combination of an intravenous injection and an epidural injection. In Sam’s case, VetStem and Dr. Roberts agreed an intravenous injection and an epidural injection might be the best choice for Sam. Sam received his follow up injections just under two weeks after his initial treatment.

Following treatment with these regenerative cells, Sam’s owner performed stretching and rehabilitation exercises at home to help with his healing. She reported that within three months, Sam’s joints were at 100% range of motion and his activity level improved. He continues to receive accupuncture, laser therapy, and supplements which his owner believes keeps him feeling his best. She states, “Some days he runs like a crazy man and wants to play with his dog friends at the park. Other times he runs in big circles and wants me to chase him.” In his older age, Sam is not as active as he was as a puppy, but his owner stated, “Every day I thank VetStem for their procedure which has changed Sam's life. I recommend it to every pet owner who has mobility issues.”

Stem cells are regenerative cells that can differentiate into many tissue types; they have been shown in published literature to reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. Sam’s case was handled under VetStem’s clinical research program, as there is limited data to support the use of stem cell therapy in the treatment of spinal arthritis. Any inquiries regarding treatment of similar conditions or other non-standard indications should be directed to VetStem personnel.

About Lucy Roberts, DVM
Dr. Roberts grew up in Tampa, Florida, where she first began working in veterinary clinics. After graduating from the University of California Davis School of Veterinary Medicine in 2001, she finished an internship at the Colorado State University College of Veterinary Medicine in 2002. Dr. Roberts has since worked in private practice as a veterinarian for large and now small animals. She has a special interest in behavioral medicine and surgery, and she really enjoys getting to know every patient. Dr. Roberts has been VetStem Certified since 2010.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology news :

1. Labrador Retriever Gets Back to Playing Fetch After Receiving VetStem Regenerative Stem Cell Therapy
2. VetStem Biopharma is Pleased to Share the Success Story of Mandy, who was Treated with Stem Cell Therapy by Dr. Jerrold Bausman at VCA Vet Specialists of the Valley
3. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
4. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
5. First drug candidate from NIH program acquired by biopharmaceutical company
6. Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
7. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
8. Dr. Deborah French Shares Insight on Validation of Clinical LC-MS/MS in Educational Webinar
9. Biomass Boiler Market Boilers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
10. 43% Would Share Biometric Data With Health Insurance Company
11. Focused Ion Beam Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021
Post Your Comments:
(Date:12/13/2018)... ... 13, 2018 , ... Biocompare, the leading online information resource ... Need to Know about Antibody Manufacturing” . This educational resource is the third ... this film is to educate scientists about antibody production, validation, and responsible sourcing. ...
(Date:12/6/2018)... ... , ... Stewart has been on the business side of ... During his recent five-year tenure with InSphero he was the US General Manger ... in Brunswick, Maine. Through these experiences, Stewart has a deep understanding of the ...
(Date:12/5/2018)... ... December 03, 2018 , ... uBiome, the leader in microbial ... the Division of Gastroenterology and Hepatology at UC San Diego and staff gastroenterologist ... the board of leading scientists and doctors from around the world, Dr. Zarrinpar ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos ... its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is an orally active ... took place in South Korea. , This Phase 1 randomized, double-blind, placebo-controlled ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... 17, 2018 , ... ABCT , the Accelerator for ... to participate in the annual program. Twelve ventures will participate in the 6.5-month-long ... network. All startups receive an entrepreneur coach, access to active business professionals and ...
(Date:12/13/2018)... ... December 11, 2018 , ... ... and nurses can use to quickly detect Clostridium difficile (C. diff), a dangerous ... of a handheld device that can be used onsite in doctor’s offices and ...
Breaking Biology Technology: